Open AccessPB1983: TRIAL‐IN‐PROGRESS: PHASE II STUDY OF PHE885, A B‐CELL MATURATION ANTIGEN‐DIRECTED CHIMERIC ANTIGEN RECEPTOR T‐CELL THERAPY, IN ADULTS WITH RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA
Author(s) -
Munshi N.,
Spencer A.,
Raab M. S.,
Masood A.,
MartinezPrieto M.,
Chu J.,
Iida S.,
Lonial S.,
Dimopoulos M. A.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000850768.54900.41
Subject(s) - medicine , population , antigen , leukapheresis , oncology , phases of clinical research , immunophenotyping , multiple myeloma , immunology , clinical trial , stem cell , biology , environmental health , cd34 , genetics